A pharmacokinetic study to assess the comparative bioavailability of 17-B-estradiol from Metered-Dose Transdermal Sprays (MDTS) and Estraderm 50 patches as hormone replacement therapy in postmenopausal women.

Phase 1

Completed

• Conditions: Hormone replacement therapy in postmenopausal women; Reproductive Health and Childbirth - Menstruation and menopause

• Registration Number: ACTRN12605000468628
• Lead Sponsor: FemPharm Pty Ltd and/or Acrux DDS Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 12

Inclusion Criteria

Healthy post-menopausal women

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pharmacokinetic parameters - serum concentration of estradiol[On day 1 and 6 - 8.]

Secondary Outcome Measures

Name	Time	Method
Safety and Tolerability[]